688075 安旭生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产640,581-0.81%645,780339,937139,24271,078
在建工程58,17723.51%47,10391,42153,7504,281
无形资产51,609-5.62%54,68241,58622,1784,494
商誉0--0000
其他非流动资产210,183-8.72%230,252272,02385,8696,101
960,549-1.77%977,817744,968301,03985,953

流动资产
货币资金652,39093.38%337,3552,138,1602,047,209613,342
应收账款198,0831.11%195,900240,293514,297250,375
存货171,840-12.83%197,132197,296243,346126,317
其他流动资产3,813,591-6.56%4,081,3363,630,357174,55224,924
4,835,9040.50%4,811,7236,206,1072,979,4051,014,958

流动负债
短期借款1,000-66.67%3,0002,00000
应付票据41,532-59.47%102,482165,44787,22815,406
应付帐款350,493-6.07%373,149868,209324,012167,579
其他流动负债122,80778.30%68,875322,638246,090100,452
515,832-5.79%547,5061,358,294657,330283,437
流动资产净值4,320,0721.31%4,264,2164,847,8132,322,075731,521
资产总额减流动负债5,280,6210.74%5,242,0335,592,7802,623,114817,474

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债109,350-19.78%136,321174,00916,6165,783
109,350-19.78%136,321174,00916,6165,783

总权益
    实收股本127,0830.00%127,08390,77361,33346,000
    储备项目5,047,7931.31%4,982,3835,331,1632,545,164765,691
股东权益5,174,8761.28%5,109,4665,421,9362,606,497811,691
非控股权益(3,604)-4.00%(3,754)(3,165)00